Literature DB >> 12164881

A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy.

Shin Goto1, Ichiei Narita, Noriko Saito, Yasuo Watanabe, Hajime Yamazaki, Minoru Sakatsume, Hisaki Shimada, Shinichi Nishi, Mitsuhiro Ueno, Kohei Akazawa, Masaaki Arakawa, Fumitake Gejyo.   

Abstract

BACKGROUND: The M235T polymorphism of the angiotensinogen gene (AGT) is associated with an increased risk of primary hypertension, which may then lead to progressive renal disease. Recent studies showed that nucleotide substitution in the 5' upstream core promoter region of AGT affects the basal transcription rate of the gene.
METHODS: To evaluate the role of AGT polymorphisms in the progression of IgA nephropathy (IgAN), we analyzed the association of A(-20)C and M235T polymorphisms with renal prognosis in histologically-proven IgAN patients using the Kaplan-Meier method and Cox proportional hazards regression model.
RESULTS: The incidence of hypertension during the course was associated with T235, but not with C(-20). The renal survival rate for 137 patients with creatinine clearance (C(Cr)) of 70 mL/min or greater at the time of renal biopsy, and follow-up time of two years or more was significantly lower in the patients with C(-20) (P = 0.008). The Cox proportional hazards regression model showed an increased hazard ratio (HR) for urinary protein (more than 2 g/day) of 28.3 (95% CI, 7.3 to 109.8; P < 0.001), hypertension at the time of renal biopsy of 4.6 (95% CI, 1.8 to 11.9; P = 0.002), and C(-20) of 3.6 (95% CI, 1.5 to 8.7; P = 0.004).
CONCLUSION: This work provides evidence that the C(-20) polymorphism of AGT, a subset of T235 alleles, is associated with progression of renal dysfunction in IgAN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164881     DOI: 10.1046/j.1523-1755.2002.00517.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts.

Authors:  My-Trang T Dang; Chenyang Gu; Jeannie I Klavanian; Katherine A Jernigan; Karen H Friderici; Yuehua Cui; Maria Molina-Molina; Julio Ancochea; Antoni Xaubet; Bruce D Uhal
Journal:  Lung       Date:  2013-05-30       Impact factor: 2.584

2.  Toll-like receptor 9 affects severity of IgA nephropathy.

Authors:  Hitoshi Suzuki; Yusuke Suzuki; Ichiei Narita; Masashi Aizawa; Masao Kihara; Takahiro Yamanaka; Tatsuya Kanou; Hiroyasu Tsukaguchi; Jan Novak; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

3.  Allele-specific expression of angiotensinogen in human subcutaneous adipose tissue.

Authors:  Sungmi Park; Ko-Ting Lu; Xuebo Liu; Tapan K Chatterjee; Steven M Rudich; Neal L Weintraub; Anne E Kwitek; Curt D Sigmund
Journal:  Hypertension       Date:  2013-05-06       Impact factor: 10.190

4.  A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy.

Authors:  Koichi Nakanishi; Mayumi Sako; Nahoko Yata; Noriyuki Aoyagi; Kandai Nozu; Ryojiro Tanaka; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2003-11-28       Impact factor: 3.714

5.  Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin A nephropathy in Korean patients.

Authors:  Hyung Jin Yoon; Ho Jun Chin; Ki Young Na; Dong-Wan Chae; Suhnggwon Kim; Un Sil Jeon; Woo Kyung Chung; Hyun Hee Lee; Jaeseok Yang; Sejoong Kim; Young-Joo Kwon; Hyun Chul Kim; Sung Bae Park; Hye Young Kim; Tae Woo Lee
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

6.  Genetic polymorphisms and the risk of accelerated renal function decline in women.

Authors:  Cynthia Cooper Worobey; Naomi D L Fisher; David Cox; John P Forman; Gary C Curhan
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.